A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis (Q37012710)
Jump to navigation
Jump to search
scientific article published on 20 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis |
scientific article published on 20 June 2012 |
Statements
1 reference
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis (English)
1 reference
Stefan Schreiber
1 reference
Paul J Rutgeerts
1 reference
Richard N Fedorak
1 reference
Daan W Hommes
1 reference
Andreas Sturm
1 reference
Daniel C Baumgart
1 reference
Brian Bressler
1 reference
John C Mansfield
1 reference
Marna Williams
1 reference
Meina Tang
1 reference
Jennifer Visich
1 reference
Xiaohui Wei
1 reference
Mary Keir
1 reference
Diana Luca
1 reference
Dimitri Danilenko
1 reference
Jackson Egen
1 reference
Sharon O'Byrne
1 reference
20 June 2012
1 reference
1122-1130
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference